Gemcitabine Resistance Induced by Interaction between Alternatively Spliced Segment of Tenascin-C and Annexin A2 in Pancreatic Cancer Cells

DOI Web Site Web Site 被引用文献2件 参考文献21件
  • Gong Xiao-Guang
    Department of Surgery, First Affiliated Hospital of Xi'an Jiaotong University
  • Lv Yun-Fu
    Department of Surgery, First Affiliated Hospital of Xi'an Jiaotong University Department of General Surgery, Hainan Provincial People's Hospital
  • Li Xin-Qiu
    Department of Surgery, First Affiliated Hospital of Xi'an Jiaotong University
  • Xu Fu-Guo
    Department of Surgery, First Affiliated Hospital of Xi'an Jiaotong University
  • Ma Qing-Yong
    Department of Surgery, First Affiliated Hospital of Xi'an Jiaotong University

この論文をさがす

抄録

Pancreatic cancer is the fourth leading cause of cancer-related death in the western countries and it is resistant to almost all cytotoxic drugs. In the current study, we explored the gemcitabine resistance induced by the interaction between Annexin A2 (ANXA2) and alternatively spliced segment of tenascin-C (TNfnA-D). In the pancreatic cancer cell culture system in vitro, it was proved that exogenous recombinant TNfnA-D combined with the cell surface ANXA2 specifically and their interaction suppressed gemcitabine-induced cytotoxicity on pancreatic cancer cells in a dose-dependent manner. Meanwhile, the TNfnA-D/ANXA2 interaction increased the phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt, inhibitory κB (IκB) kinase α/β (IKKα/β), IκBα, and p65 nuclear factor-κB (NF-κB) significantly. Inhibition of Akt and PI3K with their specific inhibitors partially reversed the suppression of gemcitabine-induced cytotoxicity elicited by TNfnA-D/ANXA2 interaction. Activation of p65 NF-κB was dependent on the phosphorylation of PI3K/Akt. The phosphorylated IKKα/β induced the phosphorylation and degradation of IκBα, the sequential phosphorylation, nuclear translocation and activation of p65 NF-κB. Pyrrolidine dithiocarbamate (PDTC) effectively blocked the activity of p65 NF-κB in response to TNfnA-D. Down-regulation of p65 NF-κB with its specific small interfering RNA (siRNA) restored the gemcitabine-induced cytotoxicity suppressed by TNfnA-D/ANXA2 interaction. For the first time, this study show that ANXA2/TNfnA-D interaction induced gemcitabine resistance via the canonical PI3K/Akt/NF-κB signaling pathways in pancreatic cancer cells. Therefore, therapy targeting ANXA2/TNfnA-D and/or p65 NF-κB may have potential clinical application for patients with pancreatic cancers.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (21)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ